ACQUIRED ENAMEL HYPOPLASIA

This adverse event was reported 2 times

These drugs are most commonly taken by patients reporting ACQUIRED ENAMEL HYPOPLASIA:

# Drug Count
0 0XYGEN 1
1 ALBUTEROL SULFATE 1
2 ARTIFICIAL TEARS 1
3 BUMETANIDE 1
4 CETIRIZINE HYDROCHLORIDE 1
5 FAMOTIDINE 1
6 FLUTICASONE PROPIONATE 1
7 FUROSEMIDE 1
8 GLYCERIN 1
9 KETOTIFEN FUMARATE 1
See all common drugs associated with ACQUIRED ENAMEL HYPOPLASIA

ACQUIRED ENAMEL HYPOPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ARTIFICIAL TEARS 1 0.0004
1 POLYVINYL ALCOHOL, POVIDONE 1 0.0004
2 SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE 1 0.0002
3 MIDODRINE HYDROCHLORIDE 1 0.0002
4 KETOTIFEN FUMARATE 1 0.0002
5 LIDOCAINE PATCH 5% 1 0.0001
6 BUMETANIDE 1 0.0000
7 MAGNESIUM OXIDE 1 0.0000
8 0XYGEN 1 0.0000
9 OXYGEN 1 0.0000
See all drugs enriched for association with ACQUIRED ENAMEL HYPOPLASIA

ACQUIRED ENAMEL HYPOPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Plasma Volume Expander [EPC] 1 0.0003
1 Non-Standardized Chemical Allergen [EPC] 1 0.0000
2 Amide Local Anesthetic [EPC] 1 0.0000
3 Antiarrhythmic [EPC] 1 0.0000
4 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
5 Prostacycline Vasodilator [EPC] 1 0.0000
6 Factor Xa Inhibitor [EPC] 1 0.0000
7 Loop Diuretic [EPC] 1 0.0000
8 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with ACQUIRED ENAMEL HYPOPLASIA